DecImmune Therapeutics (United States)
Corporate R&D · Cambridge, United States · Founded 2001
Website: decimmune.com. Corporate R&D in Cambridge, United States, founded 2001. Profile and ecosystem links on Innovative EcoSystems.
In context
DecImmune Therapeutics (United States) is one of 175 corporate R&D centers in Cambridge, Massachusetts listed in the Innovative EcoSystems registry, and one of 10,487 across the United States.
The registry lists 295 innovation ecosystem organizations in Cambridge, Massachusetts in all.
Corporate R&D centers are where established companies develop new products and processes, often in partnership with universities and startups.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More corporate R&D centers in Cambridge, Massachusetts
- FogPharma (United States)
Cambridge - Catabasis Pharmaceuticals (United States)
Cambridge - Inari Agriculture (United States)
Cambridge - Seven Bridges Genomics (United States)
Cambridge - Cerevel Therapeutics (United States)
Cambridge - Pega (United States)
Cambridge - Dimagi (United States)
Cambridge - Archemix (United States)
Cambridge
Elsewhere in Cambridge, Massachusetts
- MIT Center for Bits and Atoms- Closed to the Public
Fab lab or makerspace - Cambridge Arts Council
Government or public body - CliniWorks
Health research - Mount Auburn Cemetery
Research organization - Harvard University
University or research institute
More corporate R&D centers in the United States
- Optimal Solutions (United States)
Bridgewater - Aeon Imaging (United States)
Bloomington - Scientific Solutions (United States)
Chelmsford - MTECH Laboratories (United States)
Ballston Spa - Oncor (United States)
Dallas - Vanguard Space Technologies (United States)
San Diego - Yahoo (United States)
Sunnyvale - Nokomis (United States)
Charleroi